In his latest book, science writer and medicinal chemist Jie Jack Li guides readers through the history of viruses, vaccines, and antiviral drugs. Li chronicles the discovery and treatment of HIV/AIDS, hepatitis, influenza, and coronaviruses. Throughout, Li focuses on how viruses have shaped human history and on the individuals who developed treatments.
In his latest book, science writer and medicinal chemist Jie Jack Li guides readers through the history of viruses, vaccines, and antiviral drugs. Li chronicles the discovery and treatment of HIV/AIDS, hepatitis, influenza, and coronaviruses. Throughout, Li focuses on how viruses have shaped human history and on the individuals who developed treatments.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Jie Jack Li is the CSO of GenHouse Bio. Previously, he was VP of Discovery Chemistry at ChemPartner, an Associate Professor of Chemistry at the University of San Francisco, and a Medicinal Chemist at Pfizer and Bristol-Myers Squibb. He has authored or edited over 30 books, including Blockbuster Drugs (Oxford University Press, 2014), which won the 2015 Alpha Sigma Nu Science Book Award.
Inhaltsangabe
* Preface * Chapter 1. Virus Shaping History and Discovery of Virus * 1.1 Virus shaping history * 1.1.1 Tulipomania: bubbles of bulbs * 1.1.2 The fall of old Mexico and Peru * 1.1.3 Succession of thrones * 1.1.4 The Louisiana Purchase * 1.2 Discovery of virus * 1.2.1 The gem theory * 1.2.2 Discovery of virus * 1.2.3 Cancer-causing viruses * 1.2.4 Discovery of retrovirus * Chapter 2. HIV/AIDS Drugs, Transforming a Death Sentence to a Chronic Disease * 2.1 Discovery of the virus * 2.1.1 A death sentence * 2.1.2 Discovery of HIV and the great scientific controversy * 2.1.3 The Nobel Prize * 2.2 The first ray of hope * 2.2.1 Nucleoside antiviral drugs * 2.2.2 Non-nucleoside reverse transcriptase inhibitors * 2.3 HIV protease inhibitors * 2.3.1 HIV protease * 2.3.2 First-generation HIV protease inhibitors * 2.3.3 Second-generation HIV protease inhibitors * 2.4 HIV integrase inhibitors * 2.5 HIV Entry Inhibitors * 2.5.1 HIV fusion inhibitors * 2.5.2 CCR5 inhibitors * 2.6 Triumph of modern medicine * Chapter 3. Hepatitis Drugs * 3.1 Hepatitis A virus * 3.1.1 Discovery of hepatitis A virus * 3.1.2 Hepatitis A vaccines * 3.2 Hepatitis B virus * 3.2.1 Discovery of hepatitis B virus * 3.2.2 Hepatitis B vaccines * 3.2.3 Hepatitis B drugs * 3.3 Hepatitis C virus * 3.3.1 Discovery of Hepatitis C virus * 3.3.2 Hepatitis C virus NS3/4A protease inhibitors * 3.3.3 Hepatitis C virus NS5A replication complex inhibitors * 3.3.4 Hepatitis C virus NS5B polymerase inhibitors * 3.4 Triumph of modern medicines * Chapter 4. Influenza: A Perennial Killer * 4.1 Influenza, a perennial killer * 4.2 A virus that changed the world: the 1918 Spanish flu pandemic * 4.3 Discovery of the influenza virus * 4.4 Influenza vaccines * 4.4.1 History of vaccination * 4.4.2 History of influenza vaccines * 4.4.3 Influenza vaccines today * 4.5 Influenza drugs * 4.5.1 M2 inhibitors * 4.5.2 Influenza virus neuraminidase inhibitors * 4.5.3 Cap-dependent endonuclease https://en.wikipedia.org/wiki/Ribonuclease inhibitor * Chapter 5. Coronaviruses * 5.1 Coronavirus Drugs * 5.1.1. SARS * 5.1.2. MARS * 5.1.3. SARS-CoV-2 * 5.2 COVID-19 Vaccines * 5.2.1. Pfizer/Biotech's mRNA vaccine * 5.2.2. Johnson and Johnson's viral vector vaccine * 5.3 COVID-19 Drugs * 5.3.1. Remdesivir (Veklury) * 5.3.2. Dexamethasone * Chapter 6. Closing Remarks * Bibliography * Chemical Structures of Antiviral Drugs
* Preface * Chapter 1. Virus Shaping History and Discovery of Virus * 1.1 Virus shaping history * 1.1.1 Tulipomania: bubbles of bulbs * 1.1.2 The fall of old Mexico and Peru * 1.1.3 Succession of thrones * 1.1.4 The Louisiana Purchase * 1.2 Discovery of virus * 1.2.1 The gem theory * 1.2.2 Discovery of virus * 1.2.3 Cancer-causing viruses * 1.2.4 Discovery of retrovirus * Chapter 2. HIV/AIDS Drugs, Transforming a Death Sentence to a Chronic Disease * 2.1 Discovery of the virus * 2.1.1 A death sentence * 2.1.2 Discovery of HIV and the great scientific controversy * 2.1.3 The Nobel Prize * 2.2 The first ray of hope * 2.2.1 Nucleoside antiviral drugs * 2.2.2 Non-nucleoside reverse transcriptase inhibitors * 2.3 HIV protease inhibitors * 2.3.1 HIV protease * 2.3.2 First-generation HIV protease inhibitors * 2.3.3 Second-generation HIV protease inhibitors * 2.4 HIV integrase inhibitors * 2.5 HIV Entry Inhibitors * 2.5.1 HIV fusion inhibitors * 2.5.2 CCR5 inhibitors * 2.6 Triumph of modern medicine * Chapter 3. Hepatitis Drugs * 3.1 Hepatitis A virus * 3.1.1 Discovery of hepatitis A virus * 3.1.2 Hepatitis A vaccines * 3.2 Hepatitis B virus * 3.2.1 Discovery of hepatitis B virus * 3.2.2 Hepatitis B vaccines * 3.2.3 Hepatitis B drugs * 3.3 Hepatitis C virus * 3.3.1 Discovery of Hepatitis C virus * 3.3.2 Hepatitis C virus NS3/4A protease inhibitors * 3.3.3 Hepatitis C virus NS5A replication complex inhibitors * 3.3.4 Hepatitis C virus NS5B polymerase inhibitors * 3.4 Triumph of modern medicines * Chapter 4. Influenza: A Perennial Killer * 4.1 Influenza, a perennial killer * 4.2 A virus that changed the world: the 1918 Spanish flu pandemic * 4.3 Discovery of the influenza virus * 4.4 Influenza vaccines * 4.4.1 History of vaccination * 4.4.2 History of influenza vaccines * 4.4.3 Influenza vaccines today * 4.5 Influenza drugs * 4.5.1 M2 inhibitors * 4.5.2 Influenza virus neuraminidase inhibitors * 4.5.3 Cap-dependent endonuclease https://en.wikipedia.org/wiki/Ribonuclease inhibitor * Chapter 5. Coronaviruses * 5.1 Coronavirus Drugs * 5.1.1. SARS * 5.1.2. MARS * 5.1.3. SARS-CoV-2 * 5.2 COVID-19 Vaccines * 5.2.1. Pfizer/Biotech's mRNA vaccine * 5.2.2. Johnson and Johnson's viral vector vaccine * 5.3 COVID-19 Drugs * 5.3.1. Remdesivir (Veklury) * 5.3.2. Dexamethasone * Chapter 6. Closing Remarks * Bibliography * Chemical Structures of Antiviral Drugs
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
